Stay updated on Carboplatin and Nivolumab in mTNBC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin and Nivolumab in mTNBC Clinical Trial page.

Latest updates to the Carboplatin and Nivolumab in mTNBC Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check19 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.6%
- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check62 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed information about a Phase II clinical trial for a breast cancer treatment involving Carboplatin and Nivolumab, while retaining references to the study's collaborators and identifiers.SummaryDifference33%
- Check69 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 26, 2025.SummaryDifference0.2%
Stay in the know with updates to Carboplatin and Nivolumab in mTNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin and Nivolumab in mTNBC Clinical Trial page.